Pre-existing immunity modulates responses to mRNA boosters
Cell Reports · 2023-03 · 42 (3) · 112167
DOI: 10.1016/j.celrep.2023.112167 ↗At a glance
Journal article in Cell Reports, 2023-03. Written by Tanushree Dangi and 7 co-authors. Institution: Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Major MEDLINE topics: BNT162 Vaccine, COVID-19. Cited 49 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIDA NIH HHS, NIAID NIH HHS, NIBIB NIH HHS.
Abstract (original language)
mRNA vaccines are effective in preventing severe COVID-19, but breakthrough infections, emerging variants, and waning immunity warrant the use of boosters. Although mRNA boosters are being implemented, the extent to which pre-existing immunity influences the efficacy of boosters remains unclear. In a cohort of individuals primed with the mRNA-1273 or BNT162b2 vaccines, we report that lower antibody levels before boost are associated with higher fold-increase in antibody levels after boost, suggesting that pre-existing antibody modulates the immunogenicity of mRNA vaccines. Our studies in mice show that pre-existing antibodies accelerate the clearance of vaccine antigen via Fc-dependent mechanisms, limiting the amount of antigen available to prime B cell responses after mRNA boosters. These data demonstrate a "tug of war" between pre-existing antibody responses and de novo B cell responses following mRNA vaccination, and they suggest that transient downmodulation of antibody effector function may improve the efficacy of mRNA boosters.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
- Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
- Department of Microbiology and Immunology, University of Illinois Chicago College of Medicine, Chicago, IL 60612, USA.
- Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address: ppm@northwestern.edu.
Funding
- NIDA NIH HHS
- NIAID NIH HHS
- NIBIB NIH HHS
- National Institute on Drug Abuse
- National Institute of Biomedical Imaging and Bioengineering
Cite
APA
Dangi, T., Sanchez, S., Lew, M. H., Awakoaiye, B., Visvabharathy, L., Richner, J. M., Koralnik, I. J., & Penaloza-MacMaster, P. (2023). Pre-existing immunity modulates responses to mRNA boosters. Cell Reports, 42(3), 112167. https://doi.org/10.1016/j.celrep.2023.112167
Vancouver
Dangi T, Sanchez S, Lew MH, Awakoaiye B, Visvabharathy L, Richner JM, et al. Pre-existing immunity modulates responses to mRNA boosters. Cell Reports. 2023;42(3):112167. doi:10.1016/j.celrep.2023.112167
BibTeX
@article{Dangi2023,
author = {Dangi, Tanushree and Sanchez, Sarah and Lew, Min Han and Awakoaiye, Bakare and Visvabharathy, Lavanya and Richner, Justin M and Koralnik, Igor J and Penaloza-MacMaster, Pablo},
title = {Pre-existing immunity modulates responses to mRNA boosters},
journal = {Cell Reports},
year = {2023},
volume = {42},
number = {3},
pages = {112167},
doi = {10.1016/j.celrep.2023.112167}
}
EUVIMED